Scholars Central

Conference abstract

Is there a future in vaccine development for rheumatoid arthritis?

Authors: Charles J Malemud

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rheumatoid arthritis (RA), an autoimmune disease, arises from defective innate and adaptive immunity. Synovial joint inflammation develops from enhanced migration of activated T- and B-lymphocytes, and other cells to synovial joints as well as from deregulated resident synovial fibroblast proliferation contributing to â??apoptosis-resistanceâ?�, subchondral bone erosion and articular cartilage destruction. Inflammation is also driven by an increase in serum and synovial fluid levels of pro-inflammatory cytokines, chemokines and adhesion proteins. The etiology of RA continues to be obscure. However, recent advances in unraveling the RA autoimmune response provided evidence for the existence of anti-cyclic citrullinated antibodies (ACPA) even before RA ensues. This suggested a potential for developing a prophylactic vaccine for RA. ACPA are pathogenic and were produced in association with the HLA-DRB1 shared epitope and the PTPN22 1858T allele. Ongoing studies have examined potential vaccine strategies for RA. These included anti-cytokine and anti-autoreactive T-cell vaccines and a vaccine construct composed of autologous immunomodulatory dendritic cells which were altered by inhibiting NF-κB and then treated with 4 citrullinated peptide antigens. This vaccine has already completed a phase-I safety trial. Another vaccine exploited the endocytic receptor, DEC205 on dendritic cells to induce immune tolerance. A category of vaccines involving pcDNA-CCOL2A1 was also tested. Normal rats were immunized with pcDNA-CCOL2A1 which caused an increase in TGF-β while decreasing interferon-γ and TNF-α. Future studies employing various immunotherapeutic vaccine strategies will be required if we are to ever incorporate such a prophylactic strategy into the overall management of undifferentiated arthritis and RA.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Charles J Malemud”